Notable Labs Stock

Notable Labs provides personalized drug combination testing service for cancer patients.

Sign up today and learn more about Notable Labs Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Notable Labs Stock

Notable Labs is a personalized testing service for cancer patients that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor without a clinical trial.

Funding History

September 2017$14.8M
July 2019$40.0M

Management

Chief Executive Officer

Laurie Heilmann

Chief Business Officer

Kevin Lynch

Vice President, Research And Development

Kathryn Vanderlaag

Board Member

Adam Seabrook

Chief Medical Officer

Hiroomi Tada

Chief Operating Officer

Robbie Narang

Head of Immuno-Oncology

Markus Lacher

Investor

Zach Finkelstein

Board Of Directors

Jim Kim

Founder & Executive Chairman

Matthew De Silva

Investor

Eric Kwan

Chief Executive Officer

Thomas Bock

Founder & CEO

Matt De Silva

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo